Epitope editing enables antibody-based, non-genotoxic conditioning for stem cell transplantation, benefiting sickle cell disease and beta-thalassemia patients

Scientists developed a non-genotoxic method to edit stem cells for transplantation. This technique modifies cell surface proteins, allowing for selective enrichment of therapeutic cells. The method uses "epitope editing" to alter the KIT protein on stem cells, making them resistant to antibody-based depletion. This allows for a gentler conditioning regimen before transplantation. This approach aims to improve the safety and efficacy of stem cell therapies for genetic blood disorders like sickle cell disease and beta-thalassemia.